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Abstract 
Introduction:  
Computed tomography ventilation imaging (CTVI) is a highly accessible functional lung 
imaging modality that can unlock the potential for functional avoidance in lung cancer 
radiation therapy. Previous attempts to validate CTVI against clinical ventilation single-30 
photon emission computed tomography (V-SPECT) have been hindered by radioaerosol 
clumping artifacts. This work builds on those studies by performing the first comparison of 
CTVI with 99mTc-carbon ('Technegas'), a clinical V-SPECT modality featuring smaller 
radioaerosol particles with less clumping. 
Methods: 35 
11 lung cancer radiotherapy patients with early stage (T1/T2N0) disease received treatment 
planning four-dimensional CT (4DCT) scans paired with Technegas V/Q SPECT/CT. For 
each patient, we applied three different CTVI methods. Two of these used deformable image 
registration (DIR) to quantify breathing induced lung density changes (CTVIDIR-HU), or 
breathing induced lung volume changes (CTVIDIR-Jac) between the 4DCT exhale/inhale 40 
phases. A third method calculated the regional product of air-tissue densities (CTVIHU) and 
did not involve DIR. Corresponding CTVI and V-SPECT scans were compared using the 
Dice Similarity Coefficient (DSC) for functional defect and non-defect regions, as well as the 
Spearman correlation r computed over the whole-lung. The DIR target registration error 
(TRE) was quantified using both manual and computer selected anatomic landmarks. 45 
Results: 
Interestingly the overall best performing method (CTVIHU) did not involve DIR. For non-
defect regions, the CTVIHU, CTVIDIR-HU, and CTVIDIR-Jac methods achieved mean DSC 
values of 0.69, 0.68, and 0.54 respectively. For defect regions, the respective DSC values 
were moderate: 0.39, 0.33 and 0.44. The Spearman r values were generally weak: 0.26 for 50 
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CTVIHU, 0.18 for CTVIDIR-HU, -0.02 and for CTVIDIR-Jac. The spatial accuracy of CTVI was 
not significantly correlated with TRE, however the DIR accuracy itself was poor with TRE > 
3.6 mm on average, potentially indicative of poor quality 4DCT. Q-SPECT scans achieved 
good correlations with V-SPECT (mean r >0.6), suggesting that the image quality of 
Technegas V-SPECT was not a limiting factor in this study. 55 
Conclusion:  
We performed a validation of CTVI using clinically available 4DCT and Technegas V/Q-
SPECT for 11 lung cancer patients. The results reinforce earlier findings that the spatial 
accuracy of CTVI exhibits significant inter-patient and inter-method variability. We propose 
that the most likely factor affecting CTVI accuracy was poor image quality of clinical 4DCT. 60 
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1. Introduction 65 
CT ventilation imaging (CTVI) combines respiratory correlated four-dimensional CT 
(4D-CT) with deformable image registration (DIR) to visualize breathing-induced air volume 
changes in the lung 1,2. As 4D-CT is increasingly considered standard of care for treatment 
planning in lung cancer radiotherapy, CTVI provides “free information” permitting an 
individualised approach to the planning of lung cancer radiotherapy3,4,5. In 2016 CTVI-70 
guided functional avoidance was applied clinically for the first time6, however further work is 
still needed at the basic level to quantify the spatial accuracy of CTVI.   
The clinical gold standard for assessing regional lung function is ventilation / 
perfusion single photon emission computed tomography (V/Q-SPECT) using inhaled and 
injected radioisotopes, namely 99mTc-labeled diethylenetriamine pentacetate (DTPA) and 75 
macroaggregated albumin (MAA). Previous attempts to validate CTVI using DTPA V-
SPECT have indicated weak spatial accuracy (voxel-level correlations in the range 0.1-0.4), 
and this is partly attributed to focal clumping of DTPA in the main airways7,8,9. By 
comparison, validation of CTVI against positron emission tomography using 68Ga –labelled 
nanoparticles (‘Galligas PET’) has led to improved voxel-level correlations (in the range 0.4-80 
0.5) owing to the smaller particle size of Galligas compared to DTPA10,11,12. The main 
drawback of Galligas is that it is considered an experimental modality, and the specialised 
requirements for Galligas generation limit the opportunities for larger scale clinical validation 
of CTVI.  
The purpose of this study was to perform the first evaluation of CTVI using a 85 
different V-SPECT modality based on 99mTc- Carbon (‘Technegas’)13,14,15. Like Galligas, 
Technegas is a smaller molecule than DTPA and disperses throughout normal lung with less 
clumping and no washout. For the purposes of widespread validation of CTVI, Technegas 
has the additional advantage of being commercially available internationally. In this work, we 
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replicate the analyses of previous CTVI validation studies using Technegas V-SPECT. 90 
Specifically, we evaluate the Dice similarity coefficient (DSC) for both ventilation defect and 
non-defect regions and the Spearman correlation r evaluated across the whole lung. We test 
the three main classes of CTVI present in the literature: two of which use DIR to evaluate 
breathing-induced changes in lung volume or density as visible in 4DCT. A third method 
uses the CT number to estimate the regional product of air-tissue densities without DIR.  95 
A major challenge for CTVI validation is that there can exist large variations in CTVI 
accuracy between different subjects and different CTVI methods (see for example Figure 1, 
which exhibits the best and worst patient cases from this study). To better characterize this, 
we perform a number of analyses beyond those performed in previous studies. Namely, in 
addition to correlating CTVI with V-SPECT, we also correlate CTVI against the 100 
corresponding Q-SPECT scans to determine if the V-SPECT image quality was a limiting 
factor. We additionally investigate the influence of DIR accuracy as quantified by the target 
registration error (TRE) for both manual- and computer-selected anatomic landmarks, and 
consider the impact of time-delays between the 4DCT and V/Q-SPECT scans by generating 
CTVIs directly from the V/Q-SPECT localization CT. Finally, we calculate the correlations 105 
between V-SPECT and Q-SPECT scan directly, which is anticipated to represent an “upper 
bound” on the CTVI accuracy. 
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Figure 1: Illustrating inter-patient and inter-method variability in CTVI as compared to V/Q-
SPECT. In each panel the functional image is overlaid on the time-averaged 4DCT. These 110 
two patients were selected to include: (a) the single best case, and (b) the single worst case of 
Spearman correlation between CTVI and V-SPECT in this study. In each panel the number 
represents the Spearman correlation with V-SPECT. See text for details on the 4DCT and 
V/Q-SPECT acquisitions, and computation of the different CTVI methods (denoted by 
subscripts “DIR-HU,” “DIR-Jac” and “HU”). 115 
2. Methods and Materials 
2.1. Study Design 
11 patients were drawn from a prospective, single-arm, ethics-approved clinical trial 
through the Western Sydney Local Health District (clinical trial number 
ACTRN12614000478617). Patients were eligible if they had early stage primary non-small 120 
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cell lung cancer and were suitable for treatment with stereotactic ablative body radiotherapy 
(SABR). All patients were ≥ 18 years of age and provided written informed consent. 
Table 1: Patient characteristics 
Characteristic Value (%) 
 
Age (years) 
(mean +/- SD) 
 
 
77±8 
Sex 
 Male 
Female 
 
4 (36) 
7 (64) 
Time between 4D-CT and V/Q SPECT 
(days) mean (range) 
 
33 (1-95) 
Tumour location by lobe 
 
RUL/RML 
RLL 
LUL 
LUL 
 
 
5 (45) 
2 (18) 
4 (36) 
0 (0) 
Central vs. Peripheral Zone 
Central Zone 
Peripheral Zone 
 
3(27) 
8(73) 
Dose 
48Gy/4 
50 Gy/5 
 
9 (81) 
2 (19) 
 
PFT’s (mean +/- SD) 
FEV1* (% pred) 
FEV1/FVC * (% pred) 
DLC0+ (% pred) 
 
61±26 
 
71 ± 25 
52 ± 11 
 
Abbreviations: DLCO = diffusing capacity of the lung for 
carbon monoxide; FEV1 = forced expiratory volume in 1 
second; FVC = forced vital capacity 
*  available for 6 patients + available for 5 patients 
 
Patients underwent radiotherapy treatment planning with 4D-CT and were assessed 125 
with V/Q SPECT. Seven patients had V/Q SPECT images acquired before treatment and 4 
after radiotherapy treatment had commenced. All patients had inoperable lung cancer, and the 
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majority had significant impairment of respiratory function based on pulmonary function 
tests (PFTs) performed before treatment. The patient characteristics are shown in Table 1. 
2.2. Details of the 4D-CT, Technegas V/Q-SPECT and PFT examinations 130 
Each patient underwent a treatment planning 4DCT scan with a GE Lightspeed RT 
16- slice scanner (GE Medical Systems, Waukesha, WI). Respiratory monitoring was 
performed using the Varian RPM system (Varian Medical Systems, Palo Alto, CA) with the 
4DCT reconstructed into 10 phase bins using the Advantage 4D software (GE Healthcare).  
The 4DCT scans had 512×512 pixels with pixel size 1×1 mm2 and slice thickness 2 mm.  135 
V/Q SPECT projections and low-dose CT scans for attenuation correction were 
acquired using a Philips Brightview XCT camera. Technegas was administered prior to 
acquiring the V-SPECT, with patients instructed to take slow, deep breaths to maximise 
dispersal of the aerosol in the pulmonary parenchyma. Technetium macro-aggregated 
albumin (Tc99m-MAA) was then administered intravenously followed by Q-SPECT 140 
acquisition.  
V/Q SPECT scans comprised 64 projections with acquisition times of 10 seconds per 
projection for V-SPECT and 8 seconds per projection for Q-SPECT during tidal breathing. 
Projections were reconstructed into a 128 × 128 matrix of pixel size 4.7 mm and slice spacing 
4.7 mm using Astonish iterative reconstruction (4 iterations and 8 subsets).  145 
2.3. Alignment and segmentation of the 4DCT and V/Q-SPECT scans 
The V/Q-SPECT images were rigidly aligned to the 4DCT exhale phase image using 
the low-dose SPECT/CT in Velocity AI (Varian Medical Systems). As a result of this 
alignment procedure the V/Q-SPECT scans were linearly resampled to the 4DCT voxel 
spacing of 1×1×2 mm3. As in Ref. [11] a median filter of kernel width 7×7×7 voxels3 150 
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(9×9×18 mm3) was applied to all V/Q-SPECT images to minimize the influence of image 
noise.  
The delineation of lung lobes in 4DCT is challenging as a result of irregular-breathing 
induced truncation/duplication artefacts and also because the fissure width is thinner than the 
4DCT slice thickness. To minimize this problem, we delineated the region of interest (ROI) 155 
for each CTVI and V/Q-SPECT comparison on the 4DCT exhale phase image, as this is the 
most stable in terms of image quality. However, in several cases the right middle lobe 
boundary was still difficult to see. Therefore, the lung was divided into the following regions: 
left upper lobe (LUL), left lower lobe (LLL), right lower lobe (RLL) and the right upper lobar 
region (RULR), which included both the right upper and right middle lobes.   160 
For each patient we then defined the whole lung ROI by taking the union of the LUL, 
LLL, RLL and RULR regions. 
 
2.4. CTVI generation 
CTVIs were generated from the 4DCT scans using VESPIR (VEntilation via Scripted 165 
Pulmonary Image Registration)16 which was previously used to compare CTVI against 
Galligas PET11 and we apply the same CTVI algorithm parameters here. Briefly, the method 
performs a B-spline DIR between each adjacent pair of 4DCT phase images (e.g. we deform 
Phase 2 1, Phase 3 2, Phase 4 3, and so on), and respectively each individual DIR 
operation produces a motion field pointing from Phase 12, Phase 23, Phase 3 4, etc. 170 
As in Kipritidis et al.17 we then filtered out the error from each individual DIR process by 
assuming that the composed motion field over the whole breathing cycle should add to zero. 
Finally, we composed the corrected motion field between the exhale and inhale phase images 
which is taken as the motion associated with ventilation. The DIR used an intensity mean 
square error (MSE) similarity metric with a scalar regularization parameter λ=1 to ensure 175 
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spatial smoothness of the DIR motion fields. We performed an initial visual check of the DIR 
results by comparing the alignment of lung structures between the 4DCT exhale/inhale phase 
images both before and after DIR.  
Three types of CTVIs were then created based on different ventilation surrogates: (i) 
breathing induced lung density change (CTVIDIR-HU), (ii) breathing induced lung volume 180 
change (CTVIDIR-Jac) and (iii) the regional product of air and tissue densities (CTVIHU). The 
CTVIs were calculated by evaluating the following expressions at each voxel location x,  
1) CTVIDIR-HUሺݔሻ =  [HUex
ሺ௫ሻିHUin* ሺ௫ሻ]
ቂHUin* ሺ௫ሻାଵ଴଴଴ቃ
× [HUexሺ௫ሻାଵ଴଴଴]ଵ଴଴଴  , where HUex and HUin refer to the 
maximal exhale and registered inhale phases, which is corrected by the mass 
correction factor (∗)  185 
2)   CTVIHUሺݔሻ =  ∑ ൤HUകሺ௫ሻିଵ଴଴଴ ×
[HUകሺ௫ሻାଵ଴଴଴]
ଵ଴଴଴ ൨ 10ൗଵ଴ఝୀଵ  where HUφ(x) is the HU value at 
voxel location (x) and 4DCT phase bin φ = 1,. . .,N.  
3)  CTVIDIR-Jacሺݔሻ = [Jacሺݔሻ − 1] where Jac(x) is the Jacobian determinant of deformation.  
 
Respectively, the CTVIDIR-HU and CTVIDIR-Jac methods rely on DIR to evaluate regional 190 
Hounsfield Unit (HU) changes [1] or to calculate the Jacobian determinant of deformation 
(‘Jac’) describing regional volume change [2]. These represent the two dominant forms of 
CTVI in the literature. The third method (CTVIHU) is a streamlined approach that 
incorporates HU information from across the whole 4D cycle and does not rely on DIR11. 
CTVIHU methods are more sensitive to motion blurring than DIR based methods, with the 195 
breathing motion directly related to the spatial extent of the blurring; we would generally 
expect higher blurring at the diaphragm compared to the apex. It is also worth noting that the 
SPECT V/Q images themselves suffer from motion blur as they were acquired under free-
breathing without gating. All CTVIs were normalized by the 90th percentile of ventilation 
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inside the lung, and a median filter of kernel width 7×7×7 voxels3 (9×9×18 mm3) was applied 200 
to minimize the influence of small scale DIR errors and image noise. 
 
2.5. Segmentation of ventilation / perfusion defect and non-defect regions 
For V/Q-SPECT images, defect regions were segmented using an image-specific 
intensity threshold set at 50% of the 90th percentile within the whole lung ROI. This 205 
algorithmic approach was used in an earlier Galligas-PET study11 and provided good 
agreement between clinician and computer selected thresholds. In this study the computer-
segmented V/Q-SPECT defect regions were visually reviewed by one of the authors.  
For CTVI, there exists is no consensus on the best thresholding method. Rather we 
tested a number of different possible defect intensity thresholds set at 5% increments (i.e. 5%, 210 
10% and so on up to 95%) of the 90th percentile of ventilation within the whole lung ROI. 
For each different CTVI type, we optimised the threshold to the nearest 5% across the whole 
patient population by minimising the residual of non-defect lung volumes between CTVI and 
V-SPECT. The resulting thresholds for the CTVIDIR-HU, CTVIDIR-Jac and CTVIHU methods 
were selected as 20%, 30% and 70% of the 90th percentile ventilation, respectively. 215 
 
2.6. Voxel-based comparisons of CTVI and V/Q-SPECT 
2.6.1. Dice similarity coefficient for functional defect and non-defect regions 
The Dice similarity coefficient (DSC) describes the fractional volume overlap 
between two regions (in our case, ventilation/perfusion defect regions or non-defect regions) 220 
and takes a value in the range [0,1]. For example, the DSC for defect regions in CTVI and V-
SPECT was calculated using,  
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DSCdefect =  2 ×
|CTVIdefect ∩ SPECTdefect|
|CTVIdefect| + |SPECTdefect| 
  
where the notation “|A|” denotes the volume of a region A, and “|A ∩ B|” indicates the 225 
volume of the intersection of regions A and B. We similarly calculated DSC values for non-
defect regions. 
2.6.2. Spearman correlations in whole lung region of interest 
The whole-lung Spearman correlation r was computed between each different CTVI 
type and corresponding Technegas V/Q-SPECT scans. The Spearman r values are defined in 230 
the range [−1, 1] and indicate the degree of monotonicity of values in spatially matched 
voxels within the whole lung ROI.  
2.6.3. Assessing the Impact of DIR performance 
We assessed the dependence of CTVI accuracy on DIR performance by calculating 
the target registration error (TRE) for a set of anatomic landmark pairs defined on each 4DCT 235 
exhale and inhale phase image pair. The DIR motion field was then used to warp the inhale-
landmarks to the exhale geometry in order to calculate TRE. Two independent landmark 
selection methods were applied: one was a semi-automated (or ‘manual’) approach and the 
other was a fully-automated method. For the manual approach, one of the authors selected up 
to 50 intensity based landmark pairs in the lung parenchyma using the Utrecht iX landmark 240 
tool18. A second author then reviewed and corrected each of these landmarks where 
appropriate. The fully-automated method used the scale invariant feature transform (SIFT) 
method as implemented by Paganelli et al.19. The SIFT algorithm produced in excess of 100 
landmark pairs in the lung parenchyma for each 4DCT scan. As in our previous studies10 the 
final TRE for both landmark selection methods, excluded any landmark pairs where the (pre-245 
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DIR) landmark distance was more than 2.5 standard deviations outside the mean landmark 
displacement for that patient. 
2.6.4. Additional cross-modality comparisons using Q-SPECT  
We considered it reasonable to assume that the V/Q SPECT scans themselves should 
be well correlated, as all of the V/Q SPECT scans in our study were reviewed by a nuclear 250 
medicine physician and no notable V/Q mismatches were found. Given also that Q-SPECT 
suffers less noise than V-SPECT, and is acquired in short succession after V-SPECT, we 
computed the DSC and Spearman r-values between corresponding CTVI and Q-SPECT scan 
pairs, and also between V-SPECT and Q-SPECT scan pairs to determine if this could 
produce improved cross-modality correlations.  255 
2.6.5. Assessing the Impact of time-delays between 4DCT and V/Q-SPECT 
In order to further assess the possible influence of time delays between corresponding 
4D-CT and V/Q SPECT scans (which ranged between 1 and 95 days; see Table I), we 
calculated the linear (Pearson) correlation between the time delay in days and the Spearman r 
values between CTVI and V-SPECT. To overcome the possible influence of time-delays on 260 
the accuracy of CT ventilation, we additionally computed the DSC and Spearman r-values 
between each V-SPECT and its corresponding low-dose CT scan with the CTVIHU method 
applied. 
 
2.7. Lobar-level comparisons of CTVI and V/Q SPECT 265 
In addition to the voxel level comparisons of Sec. 2.6. it is also of interest to consider 
the accuracy of CTVI at a coarser level of spatial resolution. Similar to the study by Eslick et 
al.12  we compared CTVI and V/Q SPECT in terms of the contribution of each lobe to the 
total ventilation for that patient. This was achieved by computing the sum of CTVI values in 
each manually delineated lobar region (LLL, LUL, RLL and RULR) and dividing by the sum 270 
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of ventilation values in the whole lung ROI. We calculated the linear (Pearson) correlations 
between CTVI- and SPECT-derived lobar contributions for 44 lobar regions across the 11 
patients. 
2.8. Global comparisons (Coefficient of Variation) 
For each CTVI or SPECT image, the Coefficient of Variation (CoV) was computed 275 
by taking the ratio of the standard deviation to the mean of all voxel values within the whole 
lung ROI. The CoV provides a measure of overall image heterogeneity for the functional 
distribution and is expected to vary proportionally between CTVI and V/Q-SPECT. For each 
corresponding combination of CTVI and SPECT image, we calculated the linear (Pearson) 
correlation of CoV values across all 11 patients. 280 
3. Results 
3.1. Voxel-based comparisons of CTVI and V/Q-SPECT 
3.1.1. Dice similarity coefficient for functional defect and non-defect regions 
 Figure 2(a) shows the DSC values obtained for non-defect regions between each of the 
CTVIDIR-HU, CTVIDIR-Jac or CTVIHU methods and the corresponding V-SPECT or Q-SPECT 285 
scans across all 11 patients. Comparing CTVI with V-SPECT (white boxes), the CTVIDIR-HU, 
CTVIDIR-Jac and CTVIHU methods achieved (mean ± SD) DSC values of (0.68 ± 0.54), (0.54 ± 
0.13) and (0.69 ± 0.08), respectively. When comparing CTVI against Q-SPECT (light shaded 
boxes), the respective DSC values were slightly higher: (0.74 ± 0.14), (0.60 ± 0.14) and (0.76 
± 0.07). The best cross-modality agreement was between V-SPECT and Q-SPECT (dark 290 
shaded boxes) which had (mean ± SD) values of (0.81 ± 0.05).  
 Similarly Figure 2(b) shows the DSC values for defect regions; here the accuracy of CTVI 
was only moderate. Comparing against V-SPECT, the CTVIDIR-HU, CTVIDIR-Jac and CTVIHU 
methods achieved DSC values of (0.33 ± 0.15), (0.44 ± 0.17) and (0.39 ± 0.18) respectively. 
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The agreement between defect regions in CTVI and Q-SPECT was similar, with respective 295 
DSC values of (0.35 ± 0.15), (0.43 ± 0.14) and (0.41 ± 0.20). Once again the best observed 
agreement was between V-SPECT and Q-SPECT, with mean DSC: (0.67 ± 0.15). 
 
 
Figure 2: Boxplots showing correlation values between different CTVI methods and the 300 
corresponding V/Q-SPECT scans. Higher correlations indicate better CTVI accuracy. The 
panels show (a) DSC evaluated for non-defect regions, (b) DSC evaluated for defect regions, 
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and (c) Spearman r-values evaluated over the whole lung. In each panel, the white boxes 
refer to comparisons between CTVI and V-SPECT, light shaded boxes refer to comparisons 
between CTVI and Q-SPECT and the dark shaded boxes refer to comparisons between V-305 
SPECT and Q-SPECT. For each box, the upper, middle and lower edges of the box represent 
the upper quartile, median and lower quartile of r values over all 11 patients. 
 
3.1.2. Spearman correlations evaluated across the whole lung 
Figure 2(c) compares the voxel-wise Spearman correlations obtained between each of 310 
the CTVIDIR-HU, CTVIDIR-Jac and CTVIHU methods and V-SPECT or Q-SPECT for all 
patients. When comparing CTVI and V-SPECT, the Spearman r values were generally weak, 
with (mean ± SD) values of (0.18 ± 0.10) for CTVIDIR-HU, (-0.02 ± 0.11) for CTVIDIR-Jac and 
(0.26 ± 0.18) for CTVIHU. The performance of the DIR-based CTVIs was slightly improved 
when comparing against Q-SPECT; (0.24 ± 0.12) for CTVIDIR-HU and (0.03 ± 0.09) for 315 
CTVIDIR-Jac. The correlations between CTVIHU with Q-SPECT were not much different to the 
comparison with V-SPECT (0.24 ± 0.25). By far the best observed Spearman correlations 
were those calculated between V-SPECT and Q-SPECT directly, with (mean ± SD) values of 
(0.66 ± 0.19). For all but one patient, the correlation between V-SPECT and Q-SPECT 
exceeded the correlation between V- or Q-SPECT with any of the CTVIs.   320 
3.1.3. Assessing the Impact of Time Delays between 4DCT and V/Q SPECT scans 
We observed no significant link between the Spearman correlation values and the 
time delay between the 4DCT and SPECT scans; the Pearson correlation values were -0.13 
(p=0.69), -0.29 (p=0.39) and 0.13 (p=0.71) for the CTVI_DIR-HU, CTVI_DIR-Jac and CTVI_HU 
methods respectively. In fact, both the highest and lowest Spearman correlation between any 325 
CTVI and its corresponding V-SPECT scan occurred for time delays of 69 and 60 days 
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respectively; see Figure 1(a) and (b) respectively. Applying the CTVIHU method to the low-
dose CT, acquired on the same day as the SPECT scans, and comparing this with the 
corresponding V-SPECT scans, we found that the (mean +\- SD) Spearman correlation was 
(0.12 +\- 0.18), poorer than for the case of the CTVIHU method as applied to the 4DCT scans. 330 
This suggestive that the time delay between 4DCT and V-SPECT scans was not the dominant 
source of error in our analysis. 
3.1.4. Assessing the Impact of DIR performance 
Based on our analysis of the TRE both before and after DIR, we conclude that the 
DIR performance in this study was relatively poor. Our manual landmarking method 335 
produced between 42-48 landmarks for each patient, resulting in a (mean ± SD) TRE of (6.58 
± 2.58) mm before DIR and (4.44 ± 1.18) mm after DIR. The fully-automated SIFT method 
produced between 150-417 landmarks for each patient and resulted in similar TRE of (6.26 ± 
2.24) mm before DIR and (3.62 ± 1.33) mm after DIR. 
In the case of the manually selected landmarks, the % reduction in TRE after DIR was 340 
positively correlated with the accuracy of CTVIDIR-HU method, as compared with V-SPECT 
and measured using the Spearman r-values. In this particular case the linear correlation was 
0.52 (p=0.10). Aside from this, no other statistically significant correlations were observed 
between TRE and the Spearman-based assessment of CTVI accuracy. 
3.2. Lobar-based comparisons of CTVI and V/Q SPECT 345 
Figures 3(a) –(d) show the correlations between CTVIDIR-HU, CTVIDIR-Jac CTVIHU and 
Q-SPECT versus V-SPECT in terms of the contribution of each lobe to the total ventilation 
for that patient. Here CTVIHU performed the best out of all the CTVI methods, exhibiting 
good agreement with Technegas V-SPECT (Pearson correlation 0.79, p<0.001). Moderate to 
strong agreement was also obtained for the DIR based methods; the Pearson correlation for 350 
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CTVIDIR-HU was 0.54 (p<0.001) and for CTVIDIR-Jac it was 0.45 (p=0.002). The comparison 
between V-SPECT vs. Q-SPECT showed strong agreement at the lobar level with a linear 
correlation of 0.89 (p<0.0001). 
 
Figure 3: Comparing different functional lung images with V-SPECT in terms of the 355 
contribution of different lobar regions to the total function for that patient. The subpanels 
compare V-SPECT with: (a) CTVIDIR-HU , (b) CTVIDIR-Jac , (c) CTVIHU and (d) Q-SPECT. As 
a guide to interpreting this figure, upper and lower lobes are represented with triangles facing 
up or down, respectively. Similarly left and right-sided lobes are represented with triangles 
that are, respectively, filled on the left and right sides. In each panel, the solid lines (dashed 360 
curves) show the linear regression (95% confidence interval). The given r (p) values refer to 
the linear correlation. 
 
 
19 
 
3.3. Global comparisons (Coefficient of Variation) 365 
The image heterogeneity was assessed by calculating the CoV, which had (mean±SD) 
values of 1.16 ± 0.96, 1.46 ± 0.71 and 0.20 ± 0.06 for CTVIDIR-HU, CTVIDIR-Jac and CTVIHU 
respectively. The V and Q-SPECT images had CoV being 0.66±0.34 and 0.49±0.19 for V-
SPECT and Q-SPECT respectively.   
Figure 4 compares CoV between V-SPECT and each of the different CTVI methods 370 
(as well as Q-SPECT). Based on CoV values generated from all 11 patients, the linear 
correlation values were 0.24 (p=0.48) for CTVIDIR-HU, 0.43 (p=0.18) for CTVIDIR-Jac and 0.78 
(p<0.01) for CTVIHU.  As was the case in Sec. 3.1. and 3.2., CTVIHU was the best performing 
CTVI method, however in this case CTVIDIR-Jac appears more accurate than CTVIDIR-HU. The 
best agreement was between the V- and Q-SPECT scans, with a linear correlation 0.88 375 
(p<0.001). 
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Figure 4: Comparing different functional lung image types with V-SPECT in terms of the 
coefficient of variation (CoV). The subpanels compare V-SPECT with: (a) CTVIDIR-HU, (b) 380 
CTVIDIR-Jac, (c) CTVIHU and (d) Q-SPECT. In each panel, the solid lines (dashed curves) 
show the linear regression (95% confidence interval). The given r (p) values refer to the 
linear correlation. 
4. Discussion 
This study describes the first validation of CTVI using clinically available Technegas 385 
V-SPECT, which is important as it can inform more widespread validation of CTVI in the 
future. This study reinforces the findings of earlier studies that the spatial accuracy of CTVI 
can vary from patient-to-patient, as well as with the choice of CTVI method and the metric 
used to evaluate CTVI accuracy. Compared to V-SPECT, the overall best performing CTVI 
method (CTVIHU) achieved good DSC values for non-defect regions (mean value 0.68) and 390 
moderate DSC values for defect regions (mean value 0.39). However, the Spearman 
correlations between CTVI and V-SPECT evaluated across all lung voxels were relatively 
weak (the CTVIHU method had a mean r-value of 0.26). The accuracy of CTVI appears 
stronger when evaluated at more coarse levels of spatial resolution: for example the CTVIHU 
method showed very good agreement with V-SPECT in terms of the per-lobe contribution to 395 
total lung function (linear correlation 0.79) and in terms of the CoV (linear correlation 0.78). 
Table 2: Comparison of this study with other V-SPECT Validation Papers 
Study V-SPECT 
modality 
Patient 
number 
CTVI metric DSC 
(defect) 
DSC 
 (non-
defect) 
Spearman 
r 
 
Yamamoto 
(2010)8  
 
DTPA 
 
1 
 
CTVIDIR-HU 
CTVIDIR-Jac 
 
- 
- 
 
- 
- 
 
0.03 
0.18 
 
Castillo 
(2010)7 
 
DTPA 
 
7 
 
CTVIDIR-HU 
CTVIDIR-Jac 
 
0.35 
0.32 
 
≥ 0.2 
≥ 0.2 
 
- 
- 
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Kida 
(2016)5  
DTPA 8 CTVIDIR-HU 
CTVIDIR-Jac 
- 
- 
- 
- 
0.47 
0.37 
 
This study 
 
Technegas 
 
11 
 
CTVIDIR-HU 
CTVIDIR-Jac 
CTVIHU 
 
0.33 
0.44 
0.39 
 
0.68 
0.54 
0.69 
 
0.18 
-0.02 
0.26 
 
It is instructive to put our results into perspective; Table 2 compares our DSC values 
and Spearman correlations with previous studies 5, 7, 8 comparing CTVI against V-SPECT at 400 
the voxel level. We note it is difficult to compare these studies directly, owing to differences 
in the patient cohorts, patient breathing manoeuvres, 4DCT imaging protocols, CTVI 
algorithms, ventilation image post-processing and in the time delay between 4DCT and V-
SPECT scans. Most of these earlier studies demonstrate correlations in the range (0-0.5) and 
our observations are largely consistent with that. To date, the highest Spearman correlations 405 
between CTVI and V-SPECT remain those reported by Kida et al.5 who obtained Spearman 
r=0.44 averaged over 8 patients who were imaged with DTPA, but with non-severe 
clumping. The Kida study showed that functional avoidance treatment plans derived from 
CTVI and DTPA V-SPECT can exhibit comparable functional dosimetry despite only 
moderate CTVI accuracy. Even so, more accurate CTVI would be desirable, particularly for 410 
the case highly targeted radiotherapy treatments such as SABR.  
An important component of our work was to perform a series of sub-studies to better 
characterize the variability of CTVI accuracy. One limitation of our study was the large time-
delay between 4DCT and V/Q-SPECT scans, which had a mean value of 33 days (range 1-95 
days). Notably however, we did not observe any statistically significant correlations between 415 
the length of this time delay and the agreement between CTVI and V-SPECT as quantified by 
the Spearman r-values. We also attempted to overcome the problem of time-delays by 
applying the CTVIHU method directly to the SPECT localization CT, which represents the 
“best-case scenario” in terms of anatomic and temporal alignment between CTVI and V-
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SPECT. But the CTVIHU derived from the localization CT showed only poor Spearman 420 
correlation with V-SPECT (mean r-value 0.12, less than was the case for CTVIHU derived 
from 4DCT). These observations would appear to discount the severity of time-delays 
between 4DCT and V-SPECT as the leading source of CTVI error in this study. 
Similarly, the image quality of Technegas V-SPECT did not appear to be a limiting 
factor in this study, as the different CTVI methods demonstrated similar correlations with 425 
both V-SPECT and Q-SPECT (see Figure 2). This is in contrast to the studies by Castillo et 
al.7, 20  where CTVI showed significantly better correlations with Q-SPECT than (DTPA) V-
SPECT. In our study the Spearman correlations between corresponding Technegas V-SPECT 
and Q-SPECT were good (0.66 on average); and this is the level of agreement we would 
expect for two functional lung imaging modalities that are physiologically correlated. 430 
Our study population differs from some of the previously CTVI validation papers, as 
we included only SABR patients, who have early stage lung disease. Patients who have early 
stage disease are likely to have smaller tumors that don't block airways; therefore, it could be 
that these patients are more likely to have homogenous ventilation images running the risk 
that we are comparing noise between the two imaging modalities rather than ventilation 435 
defects. However, in our patients we still found a high degree of heterogeneity, as seen for 
the worst case patient in Figure 1, who suffered from a large ventilation defect in both lower 
lobes. Across 11 patients we found CoV values with (mean±SD) values of 1.16 ± 0.96, 
1.46±0.71 and 0.20±0.06 CTVIDIR-HU, CTVIDIR-Jac and CTVIHU respectively. The CTVIDIR-HU 
CoV figures are comparable with the figures of Brennan at al21, who demonstrated a CoVof 440 
0.83 for poor functioning lung and 0.53 for good functioning lung using a DIR based HU 
method similar to that used in this study21. 
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In addition, we have examined the proportion of lung ventilated and perfused in the 
V/Q SPECT. Across all eleven patients, the mean ± SD (range) of the percentage of 445 
ventilated lung was 53.7±15.5 (26.1-77.6), and perfused lung was 62.8 ±15.2 (45.2-75.2). 
Ventilated and perfusion scans were thresholded using the same method as CTVI. This 
corresponds to the work of Vinogradskiy et al. who demonstrated significant ventilation 
defects in up to 30% early stage lung cancer patients22. The wide range supports the fact that 
there is a great deal of heterogeneity in the images. Furthermore, the % mismatch of 450 
ventilation versus perfusion was relatively small with a mean±SD (range) of 7.5±4.7 (2.4-
18.5) providing supporting evidence that the V/Q SPECT images should be well correlated 
for most patients.  
By ruling out the other possibilities, we propose that the most likely source of CTVI 
error in this study was a high prevalence of image artefacts in 4DCT due to irregular 455 
breathing. Irregular breathing is known to cause image artefacts – such as anatomic 
truncation and duplication - in up to 90% of clinical 4DCT scans3, 23 and 4DCT image quality 
is also known to impact the reproducibility of DIR-based CTVI methods23, 24. Poor 4DCT 
image quality may help to explain the observations of poor DIR accuracy in this study; both 
manual and automated landmark selection methods suggested a TRE >3.5 mm on average, 460 
which could be considered unacceptably large given a slice thickness of 2 mm but is also 
likely to be representative of most 4D-CT in clinical use.  
By comparison the same DIR was found to have a TRE <2 mm in an earlier study 
using 4D-PET/CT10. Interestingly we observed that the CTVI methods relying on DIR 
(CTVIDIR-HU and CTVIDIR-Jac) performed less well on average than a method using no DIR at 465 
all (CTVIHU). Compared to the present study, the earlier study using 4D PET/CT used a 
lower-dose setting for the 4DCT scan component, a smaller number of phase images (5 vs. 
10) and a larger slice thickness (2.5 mm versus 5 mm). Based on the comparison of scan 
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parameters, we might expect the treatment planning 4DCT scans in the current study to 
enable more accurate DIR-based CTVI since the scan parameters imply finer spatial / 470 
temporal resolution. However, a comparison in terms of scan parameters alone does not 
account for the potential problems of irregular patient breathing and related motion artifacts 
in the reconstructed 4DCT phase images.  
To understand the influence of 4DCT image artifacts, it is instructive to compare the 
following subtraction images: between the deformably-registered 4DCT exhale and inhale 475 
phase images (HU50% and HU*0%, left column), between the two phase images around 
maximal exhale (HU60% and HU50%, middle column), and between the two phase images 
around maximal inhale (HU0% and HU90%, right column). These are presented in Figure 5 
below and correspond to the “worst case” patient from Figure 1. Essentially the HU 
difference between deformably registered exhale/inhale images can be interpreted as the 480 
“ventilation signal”; indeed the CTVIDIR-HU method is directly related to this HU difference 
distribution via Eq. (1). By comparison, the differences between HU60%,HU50% and 
HU0%,HU90% can be interpreted as “noise”, featuring alternating bright/dark bands that are 4 
slices thick in the SI direction and corresponding to the abutting couch positions of the cine-
mode 4DCT scan. Noting that all panels have the same window/level settings, we observe 485 
that HU differences associated with ventilation are barely larger than the HU differences 
observed between any pair of neighbouring 4D phases. This is a problem because it suggests 
that substituting the 50% phase with the 60% phase (or similarly the 0% phase with the 90% 
phase), could lead to severe variations in the resultant CTVI. 
It is challenging to quantify the noise in the dynamic HU signal directly. For example, 490 
we attempted to quantify the 4DCT image quality in terms of changes in the normalized cross 
correlation (NCC) between adjacent slice pairs across abutting couch transitions; this is the 
method suggested by Cui et al.25 However, in our case we did not observe a significant 
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correlation between NCC metrics and the Spearman r-values between CTVI and V-SPECT. 
While the development of new 4DCT image quality metrics is beyond the scope of this study, 495 
the problem of poor ventilation signal observed in Figure 5 was qualitatively observed across 
all 11 scans in our dataset and is implicated in the poor CTVI accuracy observed in this work. 
 
Figure 5: illustrating subtraction images between different 4DCT phase image pairs for the 
“worst case” patient in Figure 1. Difference images are shown between deformably registered 500 
exhale and inhale phase images (left column), the 60%/50% phases around maximum exhale 
(middle) and the 0%,90% phases around maximum inhale (right). The arrows indicate 
spurious, artefact induced HU differences outside the lung for 4DCT phase images near 
exhale (middle column) and near inhale (right columns).  
This study represents the validation results that may be expected in a clinical 505 
environment, and therefore gives a useful indication of the robustness of CTVI in clinical 
practice. Technegas appears to be a suitable reference modality, but the quality of 4D-CT 
itself may have a significant impact on the quality of CTVI, particularly when this is DIR 
based26. In lieu of higher quality 4DCT and/or alternate DIR methods that are robust against 
stochastic image artifacts, we therefore suggest that the CTVIHU method may prove the most 510 
reliable CTVI method for use with clinical 4DCT. Whilst this is still an early result, we aim 
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to incorporate this dataset into a larger validation dataset in the future, to further investigate 
the robustness of validation between CTVI and Technegas V-SPECT.  
5. Conclusions 
 Our study compared CTVI with Technegas V-SPECT for 11 lung cancer SABR 515 
patients, demonstrating good agreement between CTVI and Technegas V-SPECT in terms of 
the Dice overlap for non-defect regions, lobar level and whole lung level CoV comparisons. 
However, the Dice overlap for defect regions, as well as the voxel-wise Spearman correlation 
showed only weak-moderate agreement. Importantly, the DIR-based CTVI methods 
performed less well than a method independent of DIR, suggesting a need to optimize the 520 
image quality of clinical 4DCT to further improve the accuracy of DIR-based CTVI.  
 
 
 
  525 
27 
 
Acknowledgements and Conflicts of Interest 
We would like to acknowledge the assistance of the following staff at the Nepean Cancer 
Care Centre: Dr Peter Flynn (Chair of the Nepean Lung MDT), Dr Roland Yeghiaian-
Alvandi, Ms Shamira Cross, Mr Sean White and Ms Katrina West, who assisted with patient 
recruitment and data acquisition. Dr Kipritidis was supported by a Cancer Institute NSW 530 
Early Career Fellowship (13/ECF/1-15). Professor Keall was supported by an NHMRC 
Australia Fellowship. 
 
 
 535 
 
 
 
 
 540 
 
 
 
 
 545 
 
 
 
 
 550 
28 
 
 
References 
1.  Guerrero T, Sanders K, Castillo E, et al. Dynamic ventilation imaging from four-
dimensional computed tomography. Phys Med Biol. 2006;51:777-791. 
2.  Reinhardt JM, Ding K, Cao K, Christensen GE, Hoffman EA, Bodas SV. Registration-555 
based estimates of local lung tissue expansion compared to xenon CT measures of 
specific ventilation. Med Image Anal. 2008;12(6):752-763. 
3.  Vinogradskiy Y, Castillo R, Castillo E, et al. Use of 4-dimensional computed 
tomography-based ventilation imaging to correlate lung dose and function with clinical 
outcomes. Int J Radiat Oncol Biol Phys. 2013;86(2):366-371. 560 
4.  Yamamoto T, Kabus S, von Berg J, Lorenz C, Keall PJ. Impact of four-dimensional 
computed tomography pulmonary ventilation imaging-based functional avoidance for 
lung cancer radiotherapy. Int J Radiat Oncol Biol Phys. 2011;79(1):279-288. 
5.  Kida S, Bal M, Kabus S, et al. CT ventilation functional image-based IMRT treatment 
plans are comparable to SPECT ventilation functional image-based plans. Radiother 565 
Oncol. 2016;118(3):521-527. 
6.  Yamamoto T, Kabus S, Bal M, Keall P, Benedict S, Daly M. The first patient treatment 
of computed tomography ventilation functional image-guided radiotherapy for lung 
cancer. Radiother Oncol. 2016;118(2). 
7.  Castillo R, Castillo E, Martinez J, Guerrero T. Ventilation from four-dimensional 570 
computed tomography: density versus Jacobian methods. Phys Med Biol. 
2010;55(16):4661-4685. 
8.  Yamamoto T, Kabus S, von Berg J, et al. Evaluation of Four-dimensional (4D) 
Computed Tomography (CT) Pulmonary Ventilation Imaging by Comparison with 
Single Photon Emission Computed Tomography (SPECT) Scans for a Lung Cancer 575 
Patient. In: Proc. 3rd Int. Workshop on Pulmonary Image Analysis, MICCAI 2010. ; 
2010:117-128. 
9.  Yamamoto T, Kabus S, Lorenz C, et al. Pulmonary ventilation imaging based on 4-
dimensional computed tomography: Comparison with pulmonary function tests and 
SPECT ventilation images. Int J Radiat Oncol Biol Phys. 2014;90(2):414-422. 580 
10.  Kipritidis J, Siva S, Hofman MS, Callahan J, Hicks RJ, Keall PJ. Validating and 
improving CT ventilation imaging by correlating with ventilation 4D-PET/CT using 
68Ga-labeled nanoparticles. Med Phys. 2014;41(1):011910. 
11.  Kipritidis J, Hofman MS, Siva S, et al. Estimating lung ventilation directly from 4D CT 
Hounsfield unit values. Med Phys. 2016;43(1):33-43. 585 
12.  Eslick EM, Bailey DL, Harris B, et al. Measurement of preoperative lobar lung function 
with computed tomography ventilation imaging: progress towards rapid stratification of 
lung cancer lobectomy patients with abnormal lung function. Eur J Cardiothorac Surg. 
2015:1-8. 
29 
 
13.  James JM, Lloyd JJ, Leahy BC, et al. 99TcmTechnegas and krypton-81m ventilation 590 
scintigraphy: a comparison in known respiratory disease. Br J Radiol. 
1992;65(780):1075-1082. 
14.  Cook G, Clarke SE. An evaluation of Technegas as a ventilation agent compared with 
krypton-81 m in the scintigraphic diagnosis of pulmonary embolism. Eur J Nucl Med 
Mol Imaging. 1992;19(9):770-774. 595 
15.  Jögi J, Jonson B, Ekberg M, Bajc M. Ventilation–perfusion SPECT with 99mTc-DTPA 
versus Technegas: a head-to-head study in obstructive and nonobstructive disease. J 
Nucl Med. 2010;51(5):735-741. 
16.  Kipritidis J, Woodruff HC, Eslick EM, Hegi-Johnson F, Keall PJ. New pathways for 
end-to-end validation of CT ventilation imaging (CTVI) using deformable image 600 
registration. In: 2016 IEEE 13th International Symposium on Biomedical Imaging 
(ISBI). IEEE; 2016:939-942. doi:10.1109/ISBI.2016.7493419. 
17.  Kipritidis J, Hugo G, Weiss E, Williamson J, Keall PJ. Measuring interfraction and 
intrafraction lung function changes during radiation therapy using four‐dimensional 
cone beam CT ventilation imaging. Med Phys. 2015;42(3):1255-1267. 605 
18.  Murphy K, van Ginneken B, Klein S, et al. Semi-automatic construction of reference 
standards for evaluation of image registration. Med Image Anal. 2011;15(1):71-84. 
19.  Paganelli C, Peroni M, Riboldi M, et al. Scale invariant feature transform in adaptive 
radiation therapy: a tool for deformable image registration assessment and re-planning 
indication. Phys Med Biol. 2012;58(2):287-299. 610 
20.  Castillo R, Castillo E, McCurdy M, et al. Spatial correspondence of 4D CT ventilation 
and SPECT pulmonary perfusion defects in patients with malignant airway stenosis. 
Phys Med Biol. 2012;57(7):1855-1871. 
21.  Brennan D, Schubert L, Diot Q, et al. Clinical Validation of 4-Dimensional Computed 
Tomography Ventilation With Pulmonary Function Test Data. Int J Radiat Oncol Biol 615 
Phys. 2015;92(2):423-429. 
22.  Vinogradskiy Y, Schubert L, Diot Q, et al. Regional lung function profiles of stage I and 
III lung cancer patients: an evaluation for functional avoidance radiation therapy. Int J 
Radiat Oncol Biol Phys. 2016;95(4):1273-1280. 
23.  Yamamoto T, Langner U, Loo BW, Shen J, Keall PJ. Retrospective analysis of artifacts 620 
in four-dimensional CT images of 50 abdominal and thoracic radiotherapy patients. Int J 
Radiat Oncol Biol Phys. 2008;72(4):1250-1258. 
24.  Yamamoto T, Kabus S, Lorenz C, et al. 4D CT lung ventilation images are affected by 
the 4D CT sorting method. Med Phys. 2013;40(10):101907. 
25.  Cui G, Jew B, Hong JC, Johnston EW, Loo Jr BW, Maxim PG. An automated method 625 
for comparing motion artifacts in cine four-dimensional computed tomography images. 
J Appl Clin Med Phys. 2012;13(6):3638-3649. 
30 
 
26.  Latifi K, Huang T-C, Feygelman V, et al. Effects of quantum noise in 4D-CT on 
deformable image registration and derived ventilation data. Phys Med Biol. 
2013;58(21):7661-7672. 630 
 
 





